Search results for "assessment."

showing 10 items of 5004 documents

Assessment and treatment of the withdrawal syndrome in paediatric intensive care units

2020

Supplemental Digital Content is available in the text

medicine.medical_specialtymedicine.drug_classIatrogenic DiseaseMEDLINEIntensive Care Units PediatricSedoanalgesia03 medical and health sciences0302 clinical medicinepaediatric intensive care unitsassessment toolsmedicineHumansopiates030212 general & internal medicineDexmedetomidineChildIntensive care medicineBenzodiazepinetreatmentbusiness.industrysedativesGold standardGeneral Medicine6200Substance Withdrawal SyndromeClonidine030220 oncology & carcinogenesisComputingMethodologies_DOCUMENTANDTEXTPROCESSINGObservational studyiatrogenic withdrawal syndromebusinessSystematic Review and Meta-AnalysisResearch Articlemedicine.drugMethadoneMedicine
researchProduct

Protrhombotic Effects of Contraceptives

2010

The use of oral contraceptives first became widespread some 40 years ago, and reports of an excess risk of cardiovascular disease among women who used these agents soon followed. Few drugs have been the object of such intensive epidemiological research, the outcome of which has provided clinicians with detailed information about risks not only of specific thrombotic diseases but also important non-contraceptive benefits from the pill. Recently, oral contraceptives have been classified by some according to "generation" (first, second, third, and most recently, fourth generation): first-generation formulations containing lynestrenol or norethindrone, second-generation formulations containing …

medicine.medical_specialtymedicine.drug_classLipid Metabolism DisordersMyocardial InfarctionPhysiologyGestodeneRisk AssessmentRisk FactorsDesogestrelInternal medicineDrug DiscoverymedicineHumansLevonorgestrelGlucose Metabolism DisordersVenous ThrombosisPharmacologyHemostasisbusiness.industryModels CardiovascularAtherosclerosisLipid MetabolismNorgestimateSettore MED/11 - Malattie Dell'Apparato CardiovascolareLynestrenolEndocrinologyEstrogenPillHypertensionFemaleRisk assessmentbusinessTrhombosis contraceptivesContraceptives Oralmedicine.drugCurrent Pharmaceutical Design
researchProduct

Early improvement as a resilience signal predicting later remission to antidepressant treatment in patients with Major Depressive Disorder: Systemati…

2017

Early improvement of depressive symptoms during the first two weeks of antidepressant treatment has been discussed to be a resilience signal predicting a later positive treatment outcome in patients with Major Depressive Disorder (MDD). However, the predictive value of early improvement varies between studies, and the use of different antidepressants may explain heterogeneous results. The objective of this review was to assess the predictive value of early improvement on later response and remission and to identify antidepressants with the highest chance of early improvement. We included 17 randomized controlled trials investigating early improvement in 14,779 adult patients with MDD compar…

medicine.medical_specialtymedicine.drug_classmedia_common.quotation_subjectMirtazapineTricyclic antidepressantPlacebolaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineOutcome Assessment Health CaremedicineHumansPsychiatryBiological Psychiatrymedia_commonDepressive Disorder MajorResilience Psychologicalmedicine.diseaseAntidepressive Agents030227 psychiatryPsychiatry and Mental healthMeta-analysisAntidepressantMajor depressive disorderPsychological resiliencePsychology030217 neurology & neurosurgerymedicine.drugJournal of psychiatric research
researchProduct

Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials

2018

Abstract Background Prediction models for venous thromboembolism recurrence will likely be improved by adding levels of coagulation factors. Risk assessment is ideally performed during anticoagulant treatment, however, the influence of direct oral anticoagulants on coagulation factors is uncertain. Objective To assess the influence of rivaroxaban and apixaban on several coagulation factor levels. Methods In two crossover trials we assessed the influence of rivaroxaban and apixaban intake on factor (F)VIII, FXI and FXII‐activity and fibrinogen, von Willebrand factor (VWF:Ag), and d‐dimer levels. At three sessions with a washout period in between, blood was taken from 12 healthy male individu…

medicine.medical_specialtymedicine.drug_mechanism_of_actionFactor Xa Inhibitorapixabanfactor Xa inhibitors030204 cardiovascular system & hematologyTreatment resultsFibrinogenGastroenterology03 medical and health sciences0302 clinical medicineVon Willebrand factorInternal medicinecoagulantsMedicinerivaroxabanBlood coagulation testRivaroxabanbiologybusiness.industryBrief Reportblood coagulation testsrisk assessmentHematologyCoagulation030220 oncology & carcinogenesisbiology.proteinApixabanbusinessOriginal Articles: Thrombosismedicine.drug
researchProduct

Update on Brugada Syndrome 2019

2021

Brugada syndrome (BrS) was first described in 1992 as an aberrant pattern of ST segment elevation in right precordial leads with a high incidence of sudden cardiac death (SCD) in patients with structurally normal heart. It represents 4% ∼ 12% of all SCD and 20% of SCD in patients with structurally normal heart. The extremely wide genetic heterogeneity of BrS and other inherited cardiac disorders makes this new area of genetic arrhytmology a fascinating one. This review shows the state of art in diagnosis, management, and treatment of BrS focusing all the aspects regarding genetics and Preimplant Genetic Diagnosis (PGD) of embryos, overlapping syndromes, risk stratification, familial screeni…

medicine.medical_specialtymedicine.medical_treatment030204 cardiovascular system & hematologyRisk Assessmentsudden cardiac deathSudden cardiac deathElectrocardiography03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansST segmentBrugada syndromeIn patient030212 general & internal medicineCardiac disordersBrugada syndromeMedicine(all)business.industryGenetic heterogeneityGeneral Medicinemedicine.diseaseImplantable cardioverter-defibrillatorBrugada Syndrome.Defibrillators ImplantableCardiologyhigh incidenceCardiology and Cardiovascular MedicinebusinessRisk assessmentCurrent Problems in Cardiology
researchProduct

Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case-Matched Control Study.

2017

Abstract Study Objective To evaluate the feasibility, surgical outcome, and oncologic results observed after robotic staging compared with conventional laparoscopic staging for patients with early-stage ovarian cancer patients. Design A retrospective cohort study (Canadian Task Force classification II-2). Setting Catholic University of the Sacred Heart, Rome, Italy. Patients Ninety-six patients underwent minimally invasive staging for presumed stage I ovarian cancer; 32 underwent the robotic approach (cases), and 64 underwent the laparoscopic approach (controls). Measurements and Main Results There was no statistically significant difference between the 2 approaches with regard to final Fed…

medicine.medical_specialtymedicine.medical_treatmentOperative TimeHysterectomy03 medical and health sciences0302 clinical medicinePostoperative ComplicationsRobotic Surgical ProceduresmedicineHumansRobotic surgeryStage (cooking)LaparoscopyAgedNeoplasm StagingRetrospective StudiesOvarian Neoplasms030219 obstetrics & reproductive medicineHysterectomymedicine.diagnostic_testbusiness.industryCase-control studyObstetrics and GynecologyRobotic Surgical ProceduresRobotic surgeryRetrospective cohort studyMiddle Agedmedicine.diseaseearly ovarian cancer; laparoscopy; robotic surgerySurgerySettore MED/40 - GINECOLOGIA E OSTETRICIAOutcome and Process Assessment Health CareItaly030220 oncology & carcinogenesisCase-Control StudiesEarly ovarian cancerFemaleLaparoscopyOvarian cancerbusinessJournal of minimally invasive gynecology
researchProduct

Importance of Residual Renal Function in Continuous Ambulatory Peritoneal Dialysis: Its Influence on Different Parameters of Renal Replacement Treatm…

1999

<i>Objective:</i> To study the influence of residual renal function (RRF) on different parameters of the renal substitutive treatment offered by peritoneal dialysis. <i>Methods:</i> We analyzed the impact of RRF on dialysis dose, nutrition parameters, anemia and phosphocalcic metabolism in 37 patients with end-stage renal disease (ESRD) treated by continuous ambulatory peritoneal dialysis (CAPD). Analytical controls were done every 6 months after an initial assessment at the end of the first month of treatment. Multiple lineal regression models were used as the statistical method to analyze the influence of RRF on different theoretically dependent factors. RRF was ca…

medicine.medical_specialtymedicine.medical_treatmentUrologyRenal functionKidneyKidney Function Testsurologic and male genital diseasesPeritoneal dialysisPhosphorus metabolismHemoglobinsPeritoneal Dialysis Continuous AmbulatoryDialysis SolutionsmedicineHumansRetrospective Studiesbusiness.industryContinuous ambulatory peritoneal dialysisAnemiaPhosphorusRetrospective cohort studymedicine.diseaseSurgeryNutrition AssessmentRenal physiologyAmbulatoryLinear ModelsKidney Failure ChronicCalciumbusinessKidney diseaseNephron
researchProduct

Impact of Age, Multimorbidity and Frailty on the Prescription of Preventive Antiplatelet Therapy in Older Population

2020

Platelet aggregation inhibitors (PAI) have widely proven their efficiency for the prevention of ischemic cardiovascular events. We aimed to describe PAI prescription in an elderly multimorbid population and to determine the factors that influence their prescription, including the impact of age, comorbidities and frailty, evaluated through a comprehensive geriatric assessment. This cross-sectional study included all patients admitted to the acute geriatric department of a university hospital from November 2016 to January 2017. We included 304 consecutive hospitalized patients aged 88.7 &plusmn

medicine.medical_specialtymultimorbidityHealth Toxicology and MutagenesisFrail ElderlyPopulationlcsh:MedicineunderuseDiseasefrailty030204 cardiovascular system & hematologyoveruseelderlyArticle03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumansMedical history030212 general & internal medicineMedical prescriptionPractice Patterns Physicians'educationplatelet aggregation inhibitorsGeriatric AssessmentAgedAged 80 and overeducation.field_of_studyMini–Mental State Examinationmedicine.diagnostic_test[SDV.MHEP.GEG] Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologybusiness.industry[SDV.MHEP.GEG]Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologylcsh:RPublic Health Environmental and Occupational HealthOdds ratiocomprehensive geriatric assessmentConfidence intervalCross-Sectional StudiesagePlatelet aggregation inhibitorFemaleantiplatelet agentsbusinessInternational Journal of Environmental Research and Public Health
researchProduct

The impact of COVID-19 on access to dental care for people with disabilities:a global survey during the COVID-19 first wave lockdown

2021

Background It is unclear what immediate impact the COVID-19 pandemic has had on delivery of oral healthcare to people with disabilities worldwide. Aim: To report the international impact of COVID-19 lockdown on oral healthcare provision for people with disabilities before, during and after the first lockdown (March to July 2020). Material and Methods Cross-sectional online self-administered survey of dentists who treat people with disabilities completed 10th to 31st of July 2020. Responses allowed comparison from before, during and immediately after the first wave lockdowns of the COVID-19 pandemic. Data were analysed using McNemar’s test to compare reported practice before to during lockdo…

medicine.medical_specialtyoral mucosal lesionsCoronavirus disease 2019 (COVID-19)prevalenceMEDLINE03 medical and health sciencesaccess0302 clinical medicineMcNemar's testSurveys and QuestionnairesHealth carePandemicoral potentially malignant disordersMedicineHumansGeneral anaesthesiaDisabled Persons030212 general & internal medicineTeledentistryDental CareGeneral DentistryPandemicsUNESCO:CIENCIAS MÉDICASbusiness.industrySARS-CoV-2ResearchCOVID-19oral cancerMedically compromised patients in Dentistry3. Good healthTest (assessment)Cross-Sectional StudiesdisabilityOtorhinolaryngologyFamily medicineCommunicable Disease Control[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieSurgerybusiness030217 neurology & neurosurgery
researchProduct

Treatment strategies and outcome of the exstrophy–epispadias complex in germany: data from the german CURE-Net

2020

Introduction: To evaluate the impact of reconstructive strategies and post-operative management on short- and long-term surgical outcome and complications of classical bladder exstrophy (CBE) patients' comprehensive data of the multicenter German-wide Network for Congenital Uro-Rectal malformations (CURE-Net) were analyzed. Methods: Descriptive analyses were performed between 34 prospectively collected CBE patients born since 2009, median 3 months old [interquartile range (IQR), 2–4 months], and 113 cross-sectional patients, median 12 years old (IQR, 6–21 years). Results: The majority of included individuals were males (67%). Sixty-eight percent of the prospectively observed and 53% of the …

medicine.medical_specialtypost-operative complicationsTherapieerfolgUrinary systemstaged approachRenal functionEpispadias030204 cardiovascular system & hematologyPediatricsBlasenekstrophie03 medical and health sciences0302 clinical medicineInterquartile rangeMedizinische Fakultät030225 pediatricstreatment strategiesmedicineKomplikationddc:610Treatment outcomePostoperative Phaseoutcome assessmentOriginal ResearchUpper urinary tractbusiness.industrylcsh:RJ1-570lcsh:PediatricsBladder exstrophy; Surgerysingle-stage approachmedicine.diseaseSurgeryBladder exstrophyInguinal herniaexstrophy–epispadias complex (EEC)Pediatrics Perinatology and Child HealthTreatment strategyoperative outcomebusinessDDC 610 / Medicine & health
researchProduct